NCT02910089View on ClinicalTrials.gov

ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

1,400

Participants

Timeline

Start Date

October 20, 2016

Primary Completion Date

December 20, 2017

Study Completion Date

December 20, 2017

Conditions

Diabetes Mellitus Type 2

Interventions

BEHAVIORAL

Shared Decision Making

This prospective study will include 700 beneficiaries of Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ).

Trial Locations (1)

2115

Research Site, Boston

Sponsors

Lead Sponsor

Collaborators (1)

Brigham Women's Health

All Listed Sponsors

collaborator

Brigham Women's Health

UNKNOWN

lead

AstraZeneca

INDUSTRY